Recombinant Human PGD Protein，GST

PGD (phosphogluconate dehydrogenase) is an enzyme that plays a pivotal role in the pentose phosphate pathway, a critical metabolic pathway responsible for producing NADPH and ribose-5-phosphate, which are essential for cellular energy metabolism and nucleotide synthesis. The study of PGD recombinant proteins has gained traction due to its potential applications in various biotechnological and medical fields, including cancer research and metabolic disorders. Abnormal PGD activity has been linked to several diseases, including certain types of cancers, where altered metabolic processes can lead to increased cell proliferation and survival. Therefore, understanding PGD’s structure and function at a molecular level through recombinant protein technology can provide insights into its role in disease mechanisms and facilitate the development of targeted therapies. Moreover, the ability to produce PGD as a recombinant protein enables researchers to investigate its enzymatic properties, regulation, and interactions with other cellular components. This research not only enhances our understanding of PGD's biological significance but also opens avenues for the design of inhibitors or modulators that could be employed in therapeutic settings. In summary, the exploration of PGD recombinant proteins represents a promising avenue for advancing our knowledge of metabolic regulation and developing novel interventions for related diseases.